Health Condition 1: M169- Osteoarthritis of hip, unspecified
Conditions
Interventions
Intervention1: Platelet-rich plasma: 4ml platelet-rich plasma, will be given once, route of administration intraarticularly into hip joint under ultrasound, guidance, total duration 30 minutes
Control
Sponsors
No Primary Sponsor
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients fulfilling 1991 American College of Rheumatology criteria for hip osteoarthritis 2. Duration of symptoms of more than 3 months 3. KL Grade 2 and 3 4. Age group 40 to 70 years 5. People who are willing to comply with the study and follow up assessments
Exclusion criteria
Exclusion criteria: 1. Infection of hip joint 2. Platelet count less than 180×1000/microliter 3. Acute and chronic systemic infections 4.Coagulopathy and Bleeding disorders 5. Impaired cognition 6. Immunosuppressed patients (eg., HIV) 7. Systemic disorders such as uncontrolled diabetes 8. Malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain by VAS scoreTimepoint: Baseline, 1 week, 4 week, 12 week and 24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Physical function by WOMAC scoreTimepoint: Baseline, 1 week, 4 week, 12 week and 24 weeks | — |
Countries
India
Contacts
Public ContactBidyabati Yumnam
Regional Institute of Medical Sciences, Imphal, Manipur
Outcome results
None listed